AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 30 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,028,000 | -7.1% | 942,000 | -5.8% | 0.01% | +60.0% |
Q2 2016 | $1,106,000 | +199.7% | 1,000,000 | +244.8% | 0.01% | +150.0% |
Q4 2015 | $369,000 | -21.3% | 290,000 | -17.1% | 0.00% | -33.3% |
Q3 2014 | $469,000 | +230.3% | 350,000 | +148.2% | 0.00% | +200.0% |
Q1 2014 | $142,000 | – | 141,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |